Literature DB >> 23319396

Short-term and long-term outcomes for patients with autoimmune pancreatitis after pancreatectomy: a multi-institutional study.

Clancy J Clark1, Vicente Morales-Oyarvide, Victor Zaydfudim, John Stauffer, Vikram Deshpande, Thomas C Smyrk, Suresh T Chari, Carlos Fernández-del Castillo, Michael B Farnell.   

Abstract

BACKGROUND: Autoimmune pancreatitis (AIP) is a rare subtype of chronic pancreatitis that may mimic adenocarcinoma of the pancreas. The aim of this study was to evaluate the short-term and long-term outcomes of pancreatectomy for patients with AIP.
METHODS: In this multi-institutional study, we identified all patients who underwent pancreatectomy for AIP from 1986 to 2011. AIP was confirmed by pathology review. Clinical presentation, operative details, and postoperative outcomes were analyzed.
RESULTS: Seventy-four patients (median age, 60 years; 69 % male) with AIP underwent pancreatectomy. The main indication for operation was concern for malignancy (n = 59, 80 %). No patients were found to have pancreatic adenocarcinoma on final pathology. Major complications occurred in ten (14 %) patients, with one perioperative death (1 %). Clinically relevant (grade B/C) pancreatic fistulae occurred in two patients. No patients required reoperation for AIP and 11 (17 %) patients developed recurrent AIP.
CONCLUSION: Although we do not advocate pancreatectomy for AIP, strong suspicion of malignancy may require an operation in selected patients. For patients with AIP, pancreatectomy resulted in few pancreatic fistulae, a low rate of re-intervention, and a 17 % recurrence rate.

Entities:  

Mesh:

Year:  2013        PMID: 23319396     DOI: 10.1007/s11605-013-2145-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy.

Authors:  Ronnie Tung Ping Poon; Siu Hung Lo; Daniel Fong; Sheung Tat Fan; John Wong
Journal:  Am J Surg       Date:  2002-01       Impact factor: 2.565

Review 2.  Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy.

Authors:  Shefali Agrawal; Cherag Daruwala; Jasvir Khurana
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

Review 3.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

4.  Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula.

Authors:  John W Lin; John L Cameron; Charles J Yeo; Taylor S Riall; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

5.  Inflammatory bowel disease in the setting of autoimmune pancreatitis.

Authors:  Karthik Ravi; Suresh T Chari; Santhi S Vege; William J Sandborn; Thomas C Smyrk; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

Review 6.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

7.  Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.

Authors:  S-H Moon; M-H Kim; D H Park; C Y Hwang; S J Park; S S Lee; D W Seo; S K Lee
Journal:  Gut       Date:  2008-06-26       Impact factor: 23.059

8.  Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma.

Authors:  Sharon M Weber; Olcay Cubukcu-Dimopulo; J Alexander Palesty; Arief Suriawinata; David Klimstra; Murray F Brennan; Kevin Conlon
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 9.  Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis.

Authors:  Makoto Otsuki; Jae Bock Chung; Kazuichi Okazaki; Myung-Hwan Kim; Terumi Kamisawa; Shigeyuki Kawa; Seung Woo Park; Tooru Shimosegawa; Kyutaek Lee; Tetsuhide Ito; Isao Nishimori; Kenji Notohara; Satoru Naruse; Shigeru B H Ko; Yasuyuki Kihara
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

Review 10.  Autoimmune pancreatitis: a challenging diagnostic puzzle for clinicians.

Authors:  E Buscarini; L Frulloni; S De Lisi; M Falconi; P A Testoni; A Zambelli
Journal:  Dig Liver Dis       Date:  2009-10-04       Impact factor: 4.088

View more
  3 in total

1.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

2.  Surgery in Autoimmune Pancreatitis.

Authors:  Sara Nikolic; Poya Ghorbani; Raffaella Pozzi Mucelli; Sam Ghazi; Francisco Baldaque-Silva; Marco Del Chiaro; Ernesto Sparrelid; Caroline S Verbeke; J-Matthias Löhr; Miroslav Vujasinovic
Journal:  Dig Surg       Date:  2021-12-15       Impact factor: 2.588

3.  Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis.

Authors:  Nicolò de Pretis; Antonio Amodio; Laura Bernardoni; Pietro Campagnola; Fabiana Capuano; Suresh T Chari; Stefano Crinò; Armando Gabbrielli; Arianna Massella; Mark Topazian; Luca Frulloni
Journal:  Clin Transl Gastroenterol       Date:  2017-04-27       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.